NEO

NeoGenomics, Inc. NASDAQ

Healthcare ·Medical - Diagnostics & Research ·US · neogenomics.com

$9.00

Pre-mkt $9.15 +1.67%

Mkt Cap $234.4M

52w Low $4.72 47.5% of range 52w High $13.74

50d MA $8.49 200d MA $9.42

P/E (TTM) -2.2x

EV/EBITDA 351.8x

P/B 0.3x

Debt/Equity 0.6x

ROE -12.0%

P/FCF -13.8x

RSI (14) —

ATR (14) —

Beta 1.71

50d MA $8.49

200d MA $9.42

Avg Volume 2.1M

About

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 28, 2026	AMC	0.01	0.01	+72.7%	9.02	+13.6%	-0.7%	+2.7%	+4.7%	—	—	—
Feb 17, 2026	AMC	0.04	0.06	+50.0%	11.44	-0.3%	-10.3%	-12.5%	-13.5%	-12.8%	-15.6%	—
Oct 28, 2025	AMC	0.02	0.03	+50.0%	9.92	+1.9%	+3.6%	-2.3%	-1.5%	-1.4%	+1.8%	—
Jul 29, 2025	AMC	0.03	0.03	+0.0%	5.25	-0.6%	-2.9%	-7.8%	-1.7%	+8.0%	+7.0%	—
Apr 29, 2025	AMC	-0.02	-0.08	-300.0%	6.58	-1.7%	-2.7%	+10.3%	+17.0%	+19.1%	+16.9%	—
Feb 18, 2025	AMC	0.03	0.04	+33.3%	12.41	-1.6%	+2.5%	-4.4%	-10.6%	-10.0%	-12.3%	—
Nov 5, 2024	AMC	0.01	0.05	+316.7%	14.93	+5.0%	+3.5%	+6.0%	+5.6%	+9.5%	+9.4%	—
Jul 29, 2024	AMC	0.00	0.03	+879.1%	14.64	+8.5%	+18.0%	+21.1%	+19.5%	+17.3%	+10.7%	—
Apr 30, 2024	AMC	-0.01	-0.02	-58.9%	13.92	+0.6%	+0.3%	+5.7%	+9.9%	+11.4%	+11.9%	—
Feb 20, 2024	AMC	0.01	0.03	+220.1%	14.70	+11.6%	+12.1%	+11.9%	+14.2%	+10.7%	+9.7%	—
Nov 6, 2023	AMC	-0.07	-0.06	+14.3%	14.65	+9.2%	+14.2%	+8.1%	+7.3%	+7.6%	+9.8%	—
Aug 8, 2023	AMC	-0.10	-0.05	+50.0%	15.32	-0.2%	-3.3%	-7.9%	-8.2%	-9.0%	-11.7%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 29	Benchmark	Upgrade	Hold → Buy	—	$9.02	$10.25	+13.6%	-0.7%	+2.7%	+4.7%	—	—
Apr 29	TD Cowen	Maintains	Buy → Buy	—	$9.02	$10.25	+13.6%	-0.7%	+2.7%	+4.7%	—	—
Apr 29	Leerink Partners	Upgrade	Market Perform → Outperform	$25	$9.02	$10.25	+13.6%	-0.7%	+2.7%	+4.7%	—	—
Feb 24	Piper Sandler	Maintains	Overweight → Overweight	—	$9.97	$10.18	+2.1%	-3.2%	-1.5%	+2.0%	-1.4%	-4.7%
Feb 17	Needham	Maintains	Buy → Buy	—	$11.38	$10.50	-7.7%	+0.5%	-9.8%	-12.0%	-13.1%	-12.4%
Jan 12	Needham	Maintains	Buy → Buy	—	$13.16	$13.26	+0.8%	-5.1%	-1.7%	+0.5%	-2.5%	-2.8%
Sep 12	TD Cowen	Maintains	Buy → Buy	—	$8.34	$8.38	+0.5%	-4.6%	-3.1%	-4.2%	-2.8%	+3.4%
Sep 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$8.78	$8.76	-0.2%	+0.3%	-6.7%	-8.2%	-9.1%	-9.7%
Aug 29	Needham	Maintains	Buy → Buy	—	$7.21	$8.78	+21.8%	+21.8%	+22.2%	+13.6%	+11.8%	+10.7%
Aug 4	Piper Sandler	Maintains	Overweight → Overweight	—	$5.16	$5.21	+1.0%	+9.9%	+8.9%	+6.4%	+11.6%	+12.4%
Jul 30	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$5.25	$5.22	-0.6%	-2.9%	-7.8%	-1.7%	+8.0%	+7.0%
Jul 29	Needham	Maintains	Buy → Buy	—	$6.46	$5.30	-18.0%	-18.7%	-21.1%	-25.1%	-20.1%	-12.2%
Jul 29	William Blair	Downgrade	Outperform → Market Perform	—	$6.46	$5.30	-18.0%	-18.7%	-21.1%	-25.1%	-20.1%	-12.2%
May 6	Piper Sandler	Maintains	Overweight → Overweight	—	$7.84	$7.83	-0.1%	-1.9%	+2.0%	+3.7%	+2.7%	+8.5%
May 1	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$6.40	$6.47	+1.1%	+13.4%	+20.3%	+22.5%	+20.2%	+25.0%
Apr 30	Goldman Sachs	Maintains	Buy → Buy	—	$6.58	$6.47	-1.7%	-2.7%	+10.3%	+17.0%	+19.1%	+16.9%
Apr 30	Leerink Partners	Downgrade	Outperform → Market Perform	—	$6.58	$6.47	-1.7%	-2.7%	+10.3%	+17.0%	+19.1%	+16.9%
Apr 29	Needham	Maintains	Buy → Buy	—	$9.97	$9.64	-3.3%	-34.0%	-35.8%	-27.2%	-22.8%	-21.4%
Apr 17	Goldman Sachs	Maintains	Buy → Buy	—	$9.56	$9.50	-0.6%	-0.1%	+0.2%	+2.0%	+3.7%	+5.5%
Feb 26	Piper Sandler	Maintains	Overweight → Overweight	—	$10.88	$10.87	-0.1%	-4.4%	-9.7%	-8.2%	-11.9%	-14.2%
Feb 19	BofA Securities	Maintains	Neutral → Neutral	—	$12.41	$12.21	-1.6%	+2.5%	-4.4%	-10.6%	-10.0%	-12.3%
Feb 19	Needham	Maintains	Buy → Buy	—	$12.41	$12.21	-1.6%	+2.5%	-4.4%	-10.6%	-10.0%	-12.3%
Jan 28	Goldman Sachs	Maintains	Buy → Buy	—	$15.04	$15.02	-0.1%	+0.9%	-3.1%	-1.6%	-4.9%	-7.7%
Jan 16	Benchmark	Maintains	Hold → Hold	—	$14.71	$14.63	-0.5%	-5.0%	-3.4%	-3.6%	-1.4%	-0.3%
Jan 15	Needham	Maintains	Buy → Buy	—	$13.78	$14.95	+8.5%	+6.7%	+1.5%	+3.1%	+2.9%	+5.2%
Jan 13	Benchmark	Downgrade	Buy → Hold	—	$14.77	$14.11	-4.5%	-14.5%	-6.7%	-0.4%	-5.3%	-3.8%
Jan 10	Needham	Maintains	Buy → Buy	—	$18.61	$17.75	-4.6%	-20.6%	-32.1%	-26.0%	-21.0%	-24.9%
Dec 13	BofA Securities	Maintains	Neutral → Neutral	—	$17.90	$17.72	-1.0%	-0.9%	+0.4%	-2.0%	-7.9%	-8.4%
Nov 6	Needham	Maintains	Buy → Buy	—	$14.93	$15.68	+5.0%	+3.5%	+6.0%	+5.6%	+9.5%	+9.4%
Sep 25	Needham	Maintains	Buy → Buy	—	$15.80	$15.78	-0.1%	-5.3%	-7.3%	-8.2%	-6.6%	-12.6%
Sep 24	Benchmark	Maintains	Buy → Buy	—	$15.80	$15.94	+0.9%	+0.0%	-5.3%	-7.3%	-8.2%	-6.6%
Jul 30	Needham	Maintains	Buy → Buy	—	$14.64	$15.89	+8.5%	+18.0%	+21.1%	+19.5%	+17.3%	+10.7%
Jul 30	Stephens & Co.	Maintains	Overweight → Overweight	—	$14.64	$15.89	+8.5%	+18.0%	+21.1%	+19.5%	+17.3%	+10.7%
Jul 30	Benchmark	Maintains	Buy → Buy	—	$14.64	$15.89	+8.5%	+18.0%	+21.1%	+19.5%	+17.3%	+10.7%
May 2	BTIG	Maintains	Buy → Buy	—	$13.96	$14.03	+0.5%	+5.4%	+9.6%	+11.1%	+11.5%	+8.4%
May 1	TD Cowen	Maintains	Buy → Buy	—	$13.92	$14.00	+0.6%	+0.3%	+5.7%	+9.9%	+11.4%	+11.9%
May 1	Benchmark	Maintains	Buy → Buy	—	$13.92	$14.00	+0.6%	+0.3%	+5.7%	+9.9%	+11.4%	+11.9%
Apr 30	Needham	Maintains	Buy → Buy	—	$15.22	$14.92	-2.0%	-8.5%	-8.3%	-3.3%	+0.5%	+1.9%
Feb 26	Piper Sandler	Maintains	Overweight → Overweight	—	$16.79	$16.87	+0.5%	-3.1%	-3.9%	-7.3%	-7.1%	-4.9%
Feb 22	Goldman Sachs	Maintains	Buy → Buy	—	$16.48	$16.69	+1.3%	-0.2%	+1.9%	-1.3%	-2.1%	-5.6%
Feb 21	Needham	Maintains	Buy → Buy	—	$14.70	$16.40	+11.6%	+12.1%	+11.9%	+14.2%	+10.7%	+9.7%
Dec 29	TD Cowen	Maintains	Outperform → Outperform	—	$16.79	$16.82	+0.2%	-3.6%	-5.0%	-4.0%	-6.1%	-7.0%
Dec 29	BTIG	Maintains	Buy → Buy	—	$16.79	$16.82	+0.2%	-3.6%	-5.0%	-4.0%	-6.1%	-7.0%
Dec 28	Needham	Maintains	Buy → Buy	—	$20.50	$18.05	-12.0%	-18.1%	-21.1%	-22.2%	-21.4%	-23.1%
Nov 8	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$16.73	$16.80	+0.4%	-5.4%	-6.0%	-5.8%	-3.9%	+4.5%
Nov 7	Needham	Maintains	Buy → Buy	—	$14.65	$16.00	+9.2%	+14.2%	+8.1%	+7.3%	+7.6%	+9.8%
Oct 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$13.71	$13.76	+0.4%	+7.6%	+6.3%	+5.8%	-0.7%	-0.7%
Oct 23	Goldman Sachs	Maintains	Buy → Buy	—	$13.90	$13.60	-2.2%	-1.4%	+6.1%	+4.8%	+4.4%	-2.1%
Oct 20	Goldman Sachs	Maintains	Buy → Buy	—	$13.77	$13.81	+0.3%	+0.9%	-0.4%	+7.1%	+5.8%	+5.4%
Oct 16	Piper Sandler	Maintains	Overweight → Overweight	—	$12.50	$12.60	+0.8%	+1.2%	+10.2%	+9.8%	+10.2%	+11.2%

Recent Filings

8-K

NeoGenomics, Inc. -- 8-K Filing

NeoGenomics achieved 15% full-year clinical revenue growth and resolved patent litigation, demonstrating operational progress and reduced legal risk for shareholders.

Feb 17

Data updated apr 26, 2026 2:39pm · Source: massive.com